Karnataka Passes Key Amendment to Drugs and Cosmetics Act
Karnataka Assembly passes the Drugs and Cosmetics (Amendment) Bill, 2024, enhancing penalties for spurious drug manufacturers and regulating online pharmacy sales. Learn the key changes.
Category : Search result: Akums Drugs and Pharmaceuticals
5 Substandard Drugs Found, Rajasthan Issues Recall
Rajasthan's drug safety body finds 5 medicines substandard, orders statewide withdrawal. Includes drugs for allergies, diabetes, and infections. Read details.
Ola Electric, RVNL, NBCC Stocks in Focus Today
Ola Electric's IPO, RVNL's new order, and NBCC's project win drive market action. Discover key details and stock movements for informed trading decisions.
Drugs Found in Car After Talapady Accident, Driver Flees
A car accident in Karnataka's Talapady led to the recovery of narcotics. The injured passenger was hospitalized while the driver, Siddique, fled the scene. Read the latest updates.
Shark Tank's Mittal on Ozempic Launch & 2026 Pharma Shift
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Delhi seals shop, seizes 204 drug samples in Bhagirath Palace raid
Delhi's Drugs Control department sealed a shop & collected 204 samples from 27 wholesale dealers in a major drive against illegal drug trade. Health Minister vows zero tolerance for spurious medicines.
Avatar: Fire and Ash India Box Office Pre-Release Report
James Cameron's Avatar: Fire and Ash gears up for a strong Indian release this weekend. Early reports suggest a ₹30-35 crore opening, facing competition from Bollywood's Dhurandhar. Read the full analysis.
Glenmark Recalls Blood Pressure Drug Ziac in US
Glenmark Pharmaceuticals recalls over 11,100 bottles of Ziac tablets in the US due to cross-contamination with a cholesterol drug. Check lot numbers and consult your doctor.
Odisha Approves Pharma & Medtech Policy 2025
Odisha's new Pharma & Medtech Policy 2025 aims to make the state a strategic hub for healthcare manufacturing. The policy includes plans for dedicated industrial parks and a roadmap aligned with India's 2047 vision. Read more.
India Seeks Trade Expansion in Russia-Led Eurasian Bloc
India aims to boost exports to the Eurasian Economic Union, tackling non-tariff barriers in pharma and marine sectors. Talks progress ahead of President Putin's visit.
Cliniexperts Completes Akynzeo Phase IV Study for Glenmark
Cliniexperts successfully concludes Phase IV study of Glenmark's Akynzeo for CINV prevention. Breakthrough in cancer care with proven efficacy and safety results.
India, Slovenia Discuss Trade and Investment Promotion
India and Slovenia explored strengthening trade, investment, and sectoral cooperation in agriculture, pharma, energy, and more. Discover the key outcomes.
Indian Companies Set for Semaglutide Device Windfall
Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.
SMS Pharma Shares Jump 17% After USFDA Nod for Ranitidine
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
India GCCs Focus on Innovation Over Scale in AI Era
India's Global Capability Centres are shifting from hiring numbers to innovation-driven outcomes. Pharma and fintech leaders reveal bold strategies prioritizing AI and blockchain over cost arbitrage.
Balaxi Pharma Soars 10% Despite 47% Yearly Loss
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Novo Nordisk brings back former CEO as chairman
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Bittu Urges Support for Chitta-Free Himachal Campaign
Union Minister Bittu appeals to Himachal residents to support anti-drug campaign. Learn how communities can fight drug menace together for a safer state.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
Nagaland DGP: Drug crisis threatens public health emergency
Nagaland's top police official warns drug menace could become public health emergency, calls for unified Northeast response. Golden Triangle proximity cited as major concern.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Biocon Banks on Weight-Loss Drugs, Ups Biosimilar Stake
Biocon's generics business surges 24% driven by weight-loss drugs liraglutide & semaglutide. CEO Siddharth Mittal reveals strategy to capture share of the booming $95 billion GLP-1 market.
Novo Nordisk cuts Wegovy price 37% in India
Novo Nordisk reduces Wegovy's price by 37% in India as it faces patent loss and competition from Eli Lilly's Mounjaro and upcoming generic versions. Discover the new costs.
Medicare Deal Slashes Obesity Drug Prices for Millions
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
Where Bengaluru's Seized Drugs Actually Go
Exclusive investigation reveals the secret journey of confiscated drugs in India's tech capital - from police vaults to scientific destruction methods that prevent environmental damage.
Trump: Deal Reached to Lower Weight Loss Drug Prices
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
White House Deal Cuts Ozempic & Wegovy Prices in India
In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.
Big Pharma Cuts Obesity Drug Prices After Trump Pressure
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
₹6.2Cr Yaba Drug Bust in Assam: Two Nabbed
In a major crackdown on drug trafficking, Assam Police intercepts huge consignment of illegal Yaba tablets in Cachar district, arresting two key suspects in coordinated operation.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
Page 2 of 4